{"id":"W3203242711","doi":"10.1007/s00259-021-05564-0","title":"Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms","year":2021,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"European Commission; Swiss Cancer Research Foundation; Neuroendocrine Tumor Research Foundation","keywords":"DOTA; Somatostatin receptor; In vivo; Medicine; Cancer research; Viability assay; Neuroendocrine tumors; Radionuclide therapy; Somatostatin receptor 2; Somatostatin; Terbium; Pharmacology; In vitro; Chemistry; Nuclear medicine; Internal medicine; Biochemistry; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257608,0.0003340285,0.0004584621,0.0002245326,0.0001002278,0.0005128999,0.0003582597,0.0003685426,0.0009115908],"category_scores_gemma":[0.0001104315,0.0001633553,0.0003060169,0.0001673542,0.0002028111,0.0004102269,0.0002998361,0.0006720604,0.0003405004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002530531,"about_ca_system_score_gemma":0.0001930504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001269416,"about_ca_topic_score_gemma":0.0003182382,"domain_scores_codex":[0.999908,0.00002945698,0.000007512336,0.00001633478,0.00001820773,0.00002050121],"domain_scores_gemma":[0.9999561,0.000009950677,0.00001145378,0.000005039844,0.000006280489,0.00001111082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006921095,0.0002735286,0.0003786338,0.0003362932,0.00004823547,0.0002557567,0.00004115373,0.0005401455,0.9600853,0.00111758,0.0005318667,0.03569947],"study_design_scores_gemma":[0.0008717155,0.0103245,0.002916062,0.00008740709,0.0002682154,0.002675819,0.0001124893,0.004317248,0.9184434,0.001167729,0.05876767,0.00004765816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8780566,0.08888574,0.02020967,0.003482014,0.0005691944,0.0003534878,0.000223796,0.0002396078,0.007979922],"genre_scores_gemma":[0.957962,0.0254597,0.01208675,0.0008378928,0.0002214917,0.0001615544,0.0001896057,0.00003420295,0.003046701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009115908,"threshold_uncertainty_score":0.003049612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0126837470383656,"score_gpt":0.2794334801016644,"score_spread":0.2667497330632987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}